Independent Living REIT plc, intends to float on the Premium Segment of the Main Market. The Company’s investment objective is to address the shortage of high-quality supported housing, delivering capital growth and inflation-linked income returns for its investors whilst providing a fair deal for society through savings for the UK taxpayer, and improved outcomes for residents. To be raised £150m. Expected 4 October 2022.
The Sustainable Farmland Trust PLC, intends to float on the Premium Segment of the Main Market. The Company invest in a diversified portfolio of farmland and related agriculture-focused assets predominantly located in the US. £200m to be raised. Due TBC.
Welkin China Private Equity, newly established closed-ended investment company dedicated to investing in unquoted Chinese companies, intends to join the Premium Segment of the Main Market. The Company is targeting a raise of up to US$300m.
Georgina Energy, focusing on the exploration, development and monetisation of helium, hydrogen and hydrocarbon interests located in Australia intends to join AIM. Georgina Energy has two principal onshore interests: (1) Mount Winter Prospect in the Amadeus Basin in Northern Australia, which the Company has a right to earn an initial 75% interest; (2) Hussar Prospect, 100% owned by the Company, located in the Officer Basin in Western Australia. Expected late September.
Altona Rare Earths, the AQSE-listed mining exploration company focused on rare earth elements projects in Africa, intends to join the Main Market. The trading of its ordinary shares on the AQSE Growth Market will be cancelled simultaneously and its EPIC will be changed from AQSE:ANR to REE. Conditionally raised £1.1m. Expected late September.
4Global 64p £16.9m (4GBL.L)
The UK-based data, services and software company focused on sport and the promotion and measurement of physical activity, announces the expansion of its DataHub into mainland Europe in conjunction with EuropeActive. The launch follows a recent successful trial in collaboration with a select group of EuropeActive’s mainland Europe fitness operators. As a result, 4GLOBAL’s DataHub will now be rolled out to gather and analyse data across the European fitness sector. Data gathered from the rollout will be used to create a European version of the Social Value Calculator product (SVC) with findings presented at European Health and Fitness Forum in 2023.
Anglo Asian Mining 72p £82.3m (AAZ.L)
The copper, gold, and silver producer in Azerbaijan, announces its interim results for the six-months ended 30 June 2022 (H1 22). Total revenues decreased 27% to $31.5m (H1 21: $43.5m) and profit before taxation decreased by 4% to $5.7m (H1 21: $5.9m). Cash was $21.2m as at 30 June 2022 (31 December 2021: cash of $37.5m) and the company remains debt free. Total production fell to 28,772 Gold Equivalent Ounces (H1 21: 32,171 GEOs) due to lower gold grades at Gedabek. The guidance for FY 2022 production is between 54,000 and 58,000 gold equivalent ounces.
Big Technologies 292.5p £849m (BIG.L)
The integrated technology platform for the remote monitoring of individuals, announces its interim results for the six-month period to 30 June 2022. Revenue increased by 27% to £22.9m (H1 21: £18m) as a result of new contract wins and an increase in business from existing customers. Monthly recurring revenue was £4.3m, up by 43%. Adjusted operating profit increased by 36% to £12.1m (H1 21: £8.9m) and adjusted EBITDA margins went up to 60.1% from 56.7% in H1 2021, thanks to increased scale and favourable currency movements. The Board expects the Group to deliver a full-year revenue of at least £48m with an adjusted EBITDA margin of in excess of 58%, ahead of current market expectations.
Checkit 20p £21.6m (CKTL)
The real-time operation management software company announces its unaudited results for the six months ended 31 July 2022 (H1 FY23). Annual recurring revenue (ARR) increased year on year by 48% to £10.2m (H1 FY22: £6.9m), reflecting upsell and customer wins. H1 recurring revenue increased by 44% to £4.4m (H1 FY22: £3.1m), representing 82% of total revenue (H1 FY22: 39%). Total revenue from continuing operations declined by 31% to £5.4m (H1 FY22: £7.9m), as a result of the previously announced discontinuance of one-off BEMS projects with minimal software input. Losses from continuing operations increased by £2m to £4.6m (H1 FY22: £2.6m) reflecting the planned winding down of the BEMS business and increased investment in the growth of the subscription business. Results are in line with Board expectations and the Board expects operating losses for FY23 to be lower than expectations set at the beginning of the year.
Croma Security Solutions 70p £10.4m (CSSG.L)
The total security services provider announces 4 new contract wins worth approx. £6.1m in annual revenue (equivalent to 17% of firm-wide sales). These contracts are: (1) two 3-year contract with a London property manager, one worth £5m p.a. for manned guarding services and the other worth £0.5m p.a. for PROception; (2) a contract with a large retail space in the North East of England worth £0.4m p.a.; (3) a contract for the iLOQ product and worth £0.3m p.a. The Group expects to announce annual results to 30 June 2022 in late October and deliver EBITDA of at least £1.5m.
Diversified Energy 131.7p £1,120.7m (DEC.L)
The independent energy company engaged in the production, marketing and transportation of primarily natural gas related to its synergistic US onshore upstream and midstream assets, announces that ESG Investing awarded Diversified Energy the Best Sustainability Reporting Award within the Basic Materials category as part of its 2022 ESG Investing Awards.
MyCelx Technologies Corp 42.5p £9.8m (MYX.L)
The clean water and clean air technology company provides a trading update. It is under contract negotiations with a major oil producer based in the Middle East and if successful, this would see the Company announce its second EOR installation deploying the patented MYCELX REGEN product. The revenue for this potential project is unlikely to be recognised in 2022 and, therefore, will be deferred to 2023. However, the Company’s other sales opportunities in the pipeline could materialize before year end. The Company has revised its guidance and now expects 10% year-on-year revenue growth for FY2022 and anticipated profitability will be adversely affected.
Oracle Power 0.245p £7.5m (ORCP.L)
The natural resources project developer announces that further to the announcement of 1 September 2022, its joint venture company, Oracle Energy Limited, has been issued a Letter of Intent (LOI) from the Directorate of Alternative Energy of the Government of Sindh, relating to the establishment of a 1,200MW hybrid solar/wind, green hydrogen/power project in Pakistan. The issuance of the LOI follows the Directorate of Alternative Energy’s confirmation of receipt of a $600k bank guarantee from Habib Metropolitan Bank, Karachi valid for 12 months, on behalf of Oracle Energy. The LOI sets out that the project developer can produce green hydrogen from a 400MW capacity electrolyser facility and renewable power for business-to-business usage, for possible sale to utilities and for other uses. In accordance with the LOI, Oracle Energy is required to complete certain milestones in the next 18 months.
Petards Group* 9.25p £5.2m (PEG.L)
The developer of advanced security and surveillance systems reports its interim results for the six months ended 30 June 2022 today. Revenue was £5.5m, down 29% (H1 2021: £7.7m) and adjusted EBITDA totalled £606k, down 35% (H1 2021: £929k), reflecting challenging conditions within the UK rail market. Gross margin improved to 49.3% (H1 2021: 39.6%) due to the re-alignment of eyeTrain’s cost base and the growth in revenue of higher margin spares, repairs, and engineering services back to pre-COVID levels. During the period, the net cashflows from operating activities was £1.1m. Net funds at 30 June 2022, after deducting term loan and lease liabilities, grew to £2.5m from £1.5m at 31 December 2021. With its existing cash resources and two years remaining on its undrawn £2.5m 3-year overdraft facility, Petards has sufficient capacity to fund organic growth and its working capital requirements.
Reabold Resources 0.355p £31.7m (RBD.L)
The investing company with a portfolio of upstream oil and gas projects, announce that further to its announcements of 4 May 2022 and 14 September 2022, it has completed the acquisition of Corallian Energy Limited’s working interest in all the non-Victory (P2596) licences within the Corallian portfolio, i.e., P2396, P2464, P2493, P2504 and P2605 (all at 100% working interest) and P2478 (36% working interest).
Disclaimer
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
